Where does Visibelle Derma Institute, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Visibelle Derma Institute, Inc. ranks #33,832 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Visibelle Derma Institute, Inc. hold?

Visibelle Derma Institute, Inc. holds 8 US utility patents granted between 2017 and 2024, spanning 7 technology areas.

What is Visibelle Derma Institute, Inc.'s Innovation Score?

Visibelle Derma Institute, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Visibelle Derma Institute, Inc. focus on?

Visibelle Derma Institute, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 7 patents, ranking #515 of 1,943 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Visibelle Derma Institute, Inc.'s patent grant rate increasing or decreasing?

Visibelle Derma Institute, Inc.'s recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Visibelle Derma Institute, Inc.'s patents?

Visibelle Derma Institute, Inc.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Visibelle Derma Institute, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Visibelle Derma Institute, Inc.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Visibelle ranks #33,832 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#33,832
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 17.1
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33832 · US Corporation #33,832 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,832/49,997
PHOTO-FINISH Viewpoint
CPC-NARROW A61N · 7 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Viewpoint, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Visibelle’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (17%) Velocity 16.7 pts (38%) Breadth 9.4 pts (21%) Claim depth 10.3 pts (23%)

Qualcomm Incorporated · highest

85
Visibelle Derma… · this assignee

44
3D Lighting… · lowest

7

What this shows Visibelle's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Visibelle?

Each dot is one of Visibelle’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Visibelle’s own 17.1 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Visibelle vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Visibelle's grants concentrate

Visibelle Derma Institute, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 87.5% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Visibelle sits between Viewpoint, Inc. and Vivace Therapeutics, Inc..

Visibelle's three-year grant acceleration

Visibelle Derma Institute, Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Viewpoint

8
Viiv Healthcare UK

8
Virtamed

8
Viscofan

8
Vision Motor Spor…

8
Visual Impact Fil…

8
Vital ART AND Sci…

8
Vivace Therapeuti…

8
Visibelle Derma I… ◀

8

What this shows Visibelle holds 8 patents at rank #33,780, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Visibelle

By rank, the assignees closest to #33,780 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Visibelle's primary technology class.

Visibelle's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Visibelle Derma Institute, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2020	1	12.5%
2021	1	12.5%
2022	3	37.5%
2024	2	25.0%

Which technologies does Visibelle Derma Institute, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 1

A47K - Sanitary Equipment NOT Otherwise Provided FOR ; Toilet Accessories 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Visibelle Derma Institute, Inc.'s patent record in context - here's where to go next.

Visibelle Derma Institute, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 87.5% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #33,832 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Visibelle Derma Institute, Inc. against Viewpoint, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.